glp-1 weight loss journey Our The GLP-1 Revolution: The Science,

Third, efforts were made to minimize potential bias due to heterogenous medication adherence in real-world patients, namely (1) the study cohort was restricted to include only stable users of study drugs to eliminate the potential confounding effect from the short-term use or non-adherence of study drugs and (2) sensitivity analyses were performed based on the AT scenario to estimate treatment effectiveness, with patients who discontinued or switched study drugs censored to corroborate our base-case analysis results based on the ITT scenario

Latzka WA, Sawka MN

No peer-reviewed stability study specific to ipamorelin has been identified

( Epub 20220713 )

Most patients report weight loss within the first four weeks